nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—SLC46A1—Metabolism of folate and pterines—MTHFR—glaucoma	0.0127	0.0514	CbGpPWpGaD
Pemetrexed—GART—Nucleotide metabolism—TXN—glaucoma	0.00961	0.0387	CbGpPWpGaD
Pemetrexed—GART—One Carbon Metabolism—MTHFR—glaucoma	0.00952	0.0384	CbGpPWpGaD
Pemetrexed—GART—eye—glaucoma	0.00797	0.156	CbGeAlD
Pemetrexed—DHFR—Metabolism of folate and pterines—MTHFR—glaucoma	0.00684	0.0276	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—ABCA1—glaucoma	0.00679	0.0274	CbGpPWpGaD
Pemetrexed—ATIC—Nucleotide metabolism—TXN—glaucoma	0.00666	0.0269	CbGpPWpGaD
Pemetrexed—ATIC—One Carbon Metabolism—MTHFR—glaucoma	0.0066	0.0266	CbGpPWpGaD
Pemetrexed—SLC46A1—eye—glaucoma	0.00647	0.127	CbGeAlD
Pemetrexed—GART—Folate Metabolism—SOD1—glaucoma	0.00605	0.0244	CbGpPWpGaD
Pemetrexed—ATIC—eye—glaucoma	0.00541	0.106	CbGeAlD
Pemetrexed—ATIC—retina—glaucoma	0.00537	0.105	CbGeAlD
Pemetrexed—ATIC—connective tissue—glaucoma	0.00522	0.102	CbGeAlD
Pemetrexed—GART—Folate Metabolism—MTHFR—glaucoma	0.0048	0.0193	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—ATOH7—glaucoma	0.00477	0.0192	CbGpPWpGaD
Pemetrexed—Tetrahydrofolic acid—MTHFR—glaucoma	0.00446	0.373	CrCbGaD
Pemetrexed—Folic Acid—MTHFR—glaucoma	0.00446	0.373	CrCbGaD
Pemetrexed—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—glaucoma	0.00379	0.0153	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—ABCA1—glaucoma	0.00366	0.0148	CbGpPWpGaD
Pemetrexed—DHFR—eye—glaucoma	0.00364	0.0713	CbGeAlD
Pemetrexed—DHFR—retina—glaucoma	0.0036	0.0706	CbGeAlD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00358	0.0144	CbGpPWpGaD
Pemetrexed—TYMS—connective tissue—glaucoma	0.00354	0.0694	CbGeAlD
Pemetrexed—DHFR—connective tissue—glaucoma	0.0035	0.0687	CbGeAlD
Pemetrexed—DHFR—Metabolism of nitric oxide—CAV1—glaucoma	0.00347	0.014	CbGpPWpGaD
Pemetrexed—DCK—Nucleotide metabolism—TXN—glaucoma	0.00346	0.014	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—SOD1—glaucoma	0.00327	0.0132	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00321	0.0129	CbGpPWpGaD
Pemetrexed—SLC29A1—connective tissue—glaucoma	0.00317	0.0622	CbGeAlD
Pemetrexed—DCK—retina—glaucoma	0.00312	0.0611	CbGeAlD
Pemetrexed—Methotrexate—MTHFR—glaucoma	0.00305	0.255	CrCbGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00287	0.0116	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CA5A—glaucoma	0.00277	0.0112	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NARFL—glaucoma	0.00277	0.0112	CbGpPWpGaD
Pemetrexed—DHFR—One Carbon Metabolism—MTHFR—glaucoma	0.00276	0.0111	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00272	0.011	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism of nitric oxide—NOS3—glaucoma	0.00262	0.0106	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—MTHFR—glaucoma	0.00259	0.0104	CbGpPWpGaD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—glaucoma	0.00248	0.00999	CbGpPWpGaD
Pemetrexed—TYMS—Nucleotide metabolism—TXN—glaucoma	0.00243	0.00979	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00242	0.00974	CbGpPWpGaD
Pemetrexed—TYMS—One Carbon Metabolism—MTHFR—glaucoma	0.00241	0.0097	CbGpPWpGaD
Pemetrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—glaucoma	0.00216	0.00871	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00216	0.00869	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00211	0.0085	CbGpPWpGaD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.00208	0.00837	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TNF—glaucoma	0.00207	0.00832	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—ABCA1—glaucoma	0.00197	0.00792	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CA5A—glaucoma	0.00192	0.00775	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NARFL—glaucoma	0.00192	0.00775	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00191	0.00771	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—OPN4—glaucoma	0.0019	0.00766	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00184	0.00741	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TP53—glaucoma	0.00182	0.00734	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—SOD1—glaucoma	0.00175	0.00706	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NARFL—glaucoma	0.0015	0.00604	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CA5A—glaucoma	0.0015	0.00604	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00146	0.00587	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.0014	0.00564	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—MTHFR—glaucoma	0.00139	0.0056	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—glaucoma	0.00136	0.00547	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—LRP12—glaucoma	0.00136	0.00546	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CA1—glaucoma	0.00135	0.00546	CbGpPWpGaD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.00132	0.00534	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CTSA—glaucoma	0.00131	0.00529	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CA2—glaucoma	0.00124	0.00499	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00123	0.00494	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TNF—glaucoma	0.00112	0.00449	CbGpPWpGaD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.00111	0.00449	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00104	0.0042	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00102	0.00412	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NARFL—glaucoma	0.001	0.00403	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CA5A—glaucoma	0.001	0.00403	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—glaucoma	0.000983	0.00396	CbGpPWpGaD
Pemetrexed—Infection—Travoprost—glaucoma	0.000982	0.00143	CcSEcCtD
Pemetrexed—Myalgia—Pilocarpine—glaucoma	0.000978	0.00142	CcSEcCtD
Pemetrexed—Arthralgia—Pilocarpine—glaucoma	0.000978	0.00142	CcSEcCtD
Pemetrexed—Chest pain—Pilocarpine—glaucoma	0.000978	0.00142	CcSEcCtD
Pemetrexed—Shock—Dorzolamide—glaucoma	0.000976	0.00142	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000972	0.00392	CbGpPWpGaD
Pemetrexed—Nausea—Levobunolol—glaucoma	0.00097	0.00141	CcSEcCtD
Pemetrexed—Infection—Brinzolamide—glaucoma	0.000969	0.00141	CcSEcCtD
Pemetrexed—Nervous system disorder—Travoprost—glaucoma	0.000969	0.00141	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—RAB8A—glaucoma	0.00096	0.00387	CbGpPWpGaD
Pemetrexed—Skin disorder—Travoprost—glaucoma	0.00096	0.00139	CcSEcCtD
Pemetrexed—Abdominal pain—Apraclonidine—glaucoma	0.000957	0.00139	CcSEcCtD
Pemetrexed—Nervous system disorder—Brinzolamide—glaucoma	0.000957	0.00139	CcSEcCtD
Pemetrexed—Rash—Latanoprost—glaucoma	0.000955	0.00139	CcSEcCtD
Pemetrexed—Agranulocytosis—Betaxolol—glaucoma	0.000954	0.00138	CcSEcCtD
Pemetrexed—Dermatitis—Latanoprost—glaucoma	0.000954	0.00138	CcSEcCtD
Pemetrexed—Dyspepsia—Acetazolamide—glaucoma	0.000953	0.00138	CcSEcCtD
Pemetrexed—Skin disorder—Brinzolamide—glaucoma	0.000948	0.00138	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000947	0.00137	CcSEcCtD
Pemetrexed—Anorexia—Dorzolamide—glaucoma	0.000946	0.00137	CcSEcCtD
Pemetrexed—Arrhythmia—Clonidine—glaucoma	0.000942	0.00137	CcSEcCtD
Pemetrexed—Decreased appetite—Acetazolamide—glaucoma	0.000941	0.00137	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CA1—glaucoma	0.000939	0.00379	CbGpPWpGaD
Pemetrexed—Oedema—Pilocarpine—glaucoma	0.000938	0.00136	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000935	0.00136	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000934	0.00377	CbGpPWpGaD
Pemetrexed—Fatigue—Acetazolamide—glaucoma	0.000934	0.00136	CcSEcCtD
Pemetrexed—Infection—Pilocarpine—glaucoma	0.000932	0.00135	CcSEcCtD
Pemetrexed—Alopecia—Clonidine—glaucoma	0.000932	0.00135	CcSEcCtD
Pemetrexed—Nausea—Methazolamide—glaucoma	0.000929	0.00135	CcSEcCtD
Pemetrexed—Dyspnoea—Brimonidine—glaucoma	0.000927	0.00134	CcSEcCtD
Pemetrexed—Shock—Pilocarpine—glaucoma	0.000923	0.00134	CcSEcCtD
Pemetrexed—Thrombocytopenia—Pilocarpine—glaucoma	0.000918	0.00133	CcSEcCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—glaucoma	0.000918	0.0037	CbGpPWpGaD
Pemetrexed—Erythema—Clonidine—glaucoma	0.000918	0.00133	CcSEcCtD
Pemetrexed—Dyspepsia—Brimonidine—glaucoma	0.000915	0.00133	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—FGFR1OP—glaucoma	0.000913	0.00368	CbGpPWpGaD
Pemetrexed—Angina pectoris—Timolol—glaucoma	0.000912	0.00132	CcSEcCtD
Pemetrexed—Pharyngitis—Betaxolol—glaucoma	0.000911	0.00132	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CTSA—glaucoma	0.00091	0.00367	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000909	0.00367	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000904	0.00131	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Travoprost—glaucoma	0.0009	0.00131	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000899	0.00362	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000897	0.00362	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Brimonidine—glaucoma	0.000897	0.0013	CcSEcCtD
Pemetrexed—Fatigue—Brimonidine—glaucoma	0.000896	0.0013	CcSEcCtD
Pemetrexed—Anorexia—Pilocarpine—glaucoma	0.000894	0.0013	CcSEcCtD
Pemetrexed—Hypersensitivity—Apraclonidine—glaucoma	0.000892	0.00129	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000891	0.00359	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000889	0.00129	CcSEcCtD
Pemetrexed—Pain—Brimonidine—glaucoma	0.000889	0.00129	CcSEcCtD
Pemetrexed—Dyspnoea—Dorzolamide—glaucoma	0.000885	0.00128	CcSEcCtD
Pemetrexed—Dyspnoea—Travoprost—glaucoma	0.000881	0.00128	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—CDKN2A—glaucoma	0.000874	0.00352	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HEYL—glaucoma	0.000874	0.00352	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR1OP—glaucoma	0.000874	0.00352	CbGpPWpGaD
Pemetrexed—Dyspepsia—Dorzolamide—glaucoma	0.000874	0.00127	CcSEcCtD
Pemetrexed—GART—Metabolism—TXN—glaucoma	0.000873	0.00352	CbGpPWpGaD
Pemetrexed—Dyspnoea—Brinzolamide—glaucoma	0.00087	0.00126	CcSEcCtD
Pemetrexed—Dyspepsia—Travoprost—glaucoma	0.00087	0.00126	CcSEcCtD
Pemetrexed—Asthenia—Apraclonidine—glaucoma	0.000869	0.00126	CcSEcCtD
Pemetrexed—Decreased appetite—Dorzolamide—glaucoma	0.000863	0.00125	CcSEcCtD
Pemetrexed—Urticaria—Acetazolamide—glaucoma	0.00086	0.00125	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CA2—glaucoma	0.000859	0.00346	CbGpPWpGaD
Pemetrexed—Dyspepsia—Brinzolamide—glaucoma	0.000859	0.00125	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—RAB8A—glaucoma	0.000859	0.00346	CbGpPWpGaD
Pemetrexed—Eye disorder—Betaxolol—glaucoma	0.000858	0.00124	CcSEcCtD
Pemetrexed—Pruritus—Apraclonidine—glaucoma	0.000856	0.00124	CcSEcCtD
Pemetrexed—Body temperature increased—Acetazolamide—glaucoma	0.000856	0.00124	CcSEcCtD
Pemetrexed—Fatigue—Dorzolamide—glaucoma	0.000856	0.00124	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000854	0.00124	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Travoprost—glaucoma	0.000853	0.00124	CcSEcCtD
Pemetrexed—Fatigue—Travoprost—glaucoma	0.000852	0.00124	CcSEcCtD
Pemetrexed—Pain—Dorzolamide—glaucoma	0.000849	0.00123	CcSEcCtD
Pemetrexed—Decreased appetite—Brinzolamide—glaucoma	0.000848	0.00123	CcSEcCtD
Pemetrexed—Pain—Travoprost—glaucoma	0.000845	0.00123	CcSEcCtD
Pemetrexed—Constipation—Travoprost—glaucoma	0.000845	0.00123	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000842	0.00122	CcSEcCtD
Pemetrexed—Asthenia—Bimatoprost—glaucoma	0.000842	0.00122	CcSEcCtD
Pemetrexed—Fatigue—Brinzolamide—glaucoma	0.000841	0.00122	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000838	0.00338	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000837	0.00337	CbGpPWpGaD
Pemetrexed—Dyspnoea—Pilocarpine—glaucoma	0.000836	0.00121	CcSEcCtD
Pemetrexed—Pain—Brinzolamide—glaucoma	0.000834	0.00121	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—OPTN—glaucoma	0.000833	0.00336	CbGpPWpGaD
Pemetrexed—Pruritus—Bimatoprost—glaucoma	0.00083	0.00121	CcSEcCtD
Pemetrexed—Diarrhoea—Apraclonidine—glaucoma	0.000828	0.0012	CcSEcCtD
Pemetrexed—Dyspepsia—Pilocarpine—glaucoma	0.000826	0.0012	CcSEcCtD
Pemetrexed—Syncope—Clonidine—glaucoma	0.000823	0.00119	CcSEcCtD
Pemetrexed—Arrhythmia—Betaxolol—glaucoma	0.00082	0.00119	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000815	0.00329	CbGpPWpGaD
Pemetrexed—Decreased appetite—Pilocarpine—glaucoma	0.000815	0.00118	CcSEcCtD
Pemetrexed—Conjunctivitis—Timolol—glaucoma	0.000812	0.00118	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dorzolamide—glaucoma	0.000812	0.00118	CcSEcCtD
Pemetrexed—Alopecia—Betaxolol—glaucoma	0.000811	0.00118	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00081	0.00118	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Travoprost—glaucoma	0.000808	0.00117	CcSEcCtD
Pemetrexed—Loss of consciousness—Clonidine—glaucoma	0.000807	0.00117	CcSEcCtD
Pemetrexed—DHFR—Metabolism—CA5A—glaucoma	0.000803	0.00324	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NARFL—glaucoma	0.000803	0.00324	CbGpPWpGaD
Pemetrexed—Pain—Pilocarpine—glaucoma	0.000802	0.00116	CcSEcCtD
Pemetrexed—Constipation—Pilocarpine—glaucoma	0.000802	0.00116	CcSEcCtD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—glaucoma	0.000801	0.00323	CbGpPWpGaD
Pemetrexed—Dizziness—Apraclonidine—glaucoma	0.0008	0.00116	CcSEcCtD
Pemetrexed—Erythema—Betaxolol—glaucoma	0.000799	0.00116	CcSEcCtD
Pemetrexed—Malnutrition—Betaxolol—glaucoma	0.000799	0.00116	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—FGFR1OP—glaucoma	0.000797	0.00321	CbGpPWpGaD
Pemetrexed—Urticaria—Dorzolamide—glaucoma	0.000788	0.00114	CcSEcCtD
Pemetrexed—Body temperature increased—Dorzolamide—glaucoma	0.000785	0.00114	CcSEcCtD
Pemetrexed—Abdominal pain—Dorzolamide—glaucoma	0.000785	0.00114	CcSEcCtD
Pemetrexed—Dysgeusia—Betaxolol—glaucoma	0.000782	0.00114	CcSEcCtD
Pemetrexed—Chest pain—Clonidine—glaucoma	0.000781	0.00113	CcSEcCtD
Pemetrexed—Arthralgia—Clonidine—glaucoma	0.000781	0.00113	CcSEcCtD
Pemetrexed—Abdominal pain—Travoprost—glaucoma	0.000781	0.00113	CcSEcCtD
Pemetrexed—Agranulocytosis—Timolol—glaucoma	0.000779	0.00113	CcSEcCtD
Pemetrexed—Asthenia—Acetazolamide—glaucoma	0.000777	0.00113	CcSEcCtD
Pemetrexed—Dizziness—Bimatoprost—glaucoma	0.000776	0.00113	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000776	0.00113	CcSEcCtD
Pemetrexed—Urticaria—Brinzolamide—glaucoma	0.000775	0.00113	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—CDKN1B—glaucoma	0.000774	0.00312	CbGpPWpGaD
Pemetrexed—Vomiting—Apraclonidine—glaucoma	0.00077	0.00112	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Pilocarpine—glaucoma	0.000767	0.00111	CcSEcCtD
Pemetrexed—Hypersensitivity—Brimonidine—glaucoma	0.000766	0.00111	CcSEcCtD
Pemetrexed—Dermatitis—Apraclonidine—glaucoma	0.000763	0.00111	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—CDKN2A—glaucoma	0.000762	0.00307	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—RAB8A—glaucoma	0.000749	0.00302	CbGpPWpGaD
Pemetrexed—Oedema—Clonidine—glaucoma	0.000749	0.00109	CcSEcCtD
Pemetrexed—Asthenia—Brimonidine—glaucoma	0.000746	0.00108	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—OPTN—glaucoma	0.000744	0.003	CbGpPWpGaD
Pemetrexed—Infection—Clonidine—glaucoma	0.000744	0.00108	CcSEcCtD
Pemetrexed—Body temperature increased—Pilocarpine—glaucoma	0.000741	0.00108	CcSEcCtD
Pemetrexed—Abdominal pain—Pilocarpine—glaucoma	0.000741	0.00108	CcSEcCtD
Pemetrexed—Diarrhoea—Acetazolamide—glaucoma	0.000741	0.00108	CcSEcCtD
Pemetrexed—Rash—Bimatoprost—glaucoma	0.00074	0.00107	CcSEcCtD
Pemetrexed—Dermatitis—Bimatoprost—glaucoma	0.000739	0.00107	CcSEcCtD
Pemetrexed—Anaemia—Betaxolol—glaucoma	0.000738	0.00107	CcSEcCtD
Pemetrexed—Shock—Clonidine—glaucoma	0.000737	0.00107	CcSEcCtD
Pemetrexed—Pruritus—Brimonidine—glaucoma	0.000735	0.00107	CcSEcCtD
Pemetrexed—Nervous system disorder—Clonidine—glaucoma	0.000734	0.00107	CcSEcCtD
Pemetrexed—Thrombocytopenia—Clonidine—glaucoma	0.000733	0.00106	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CA1—glaucoma	0.000732	0.00295	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Dorzolamide—glaucoma	0.000731	0.00106	CcSEcCtD
Pemetrexed—Hypersensitivity—Travoprost—glaucoma	0.000728	0.00106	CcSEcCtD
Pemetrexed—Skin disorder—Clonidine—glaucoma	0.000727	0.00106	CcSEcCtD
Pemetrexed—DHFR—Disease—LRP12—glaucoma	0.000727	0.00293	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—OPTN—glaucoma	0.000726	0.00293	CbGpPWpGaD
Pemetrexed—Nausea—Apraclonidine—glaucoma	0.000719	0.00104	CcSEcCtD
Pemetrexed—Hypersensitivity—Brinzolamide—glaucoma	0.000719	0.00104	CcSEcCtD
Pemetrexed—Syncope—Betaxolol—glaucoma	0.000716	0.00104	CcSEcCtD
Pemetrexed—Dizziness—Acetazolamide—glaucoma	0.000716	0.00104	CcSEcCtD
Pemetrexed—Anorexia—Clonidine—glaucoma	0.000714	0.00104	CcSEcCtD
Pemetrexed—Asthenia—Dorzolamide—glaucoma	0.000712	0.00103	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000712	0.00287	CbGpPWpGaD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.00071	0.00286	CbGpPWpGaD
Pemetrexed—Asthenia—Travoprost—glaucoma	0.000709	0.00103	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CTSA—glaucoma	0.000709	0.00286	CbGpPWpGaD
Pemetrexed—Pruritus—Dorzolamide—glaucoma	0.000702	0.00102	CcSEcCtD
Pemetrexed—Loss of consciousness—Betaxolol—glaucoma	0.000702	0.00102	CcSEcCtD
Pemetrexed—TYMS—Metabolism—NARFL—glaucoma	0.000701	0.00283	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CA5A—glaucoma	0.000701	0.00283	CbGpPWpGaD
Pemetrexed—Eye disorder—Timolol—glaucoma	0.000701	0.00102	CcSEcCtD
Pemetrexed—Asthenia—Brinzolamide—glaucoma	0.0007	0.00102	CcSEcCtD
Pemetrexed—Pruritus—Travoprost—glaucoma	0.000699	0.00101	CcSEcCtD
Pemetrexed—Nausea—Bimatoprost—glaucoma	0.000697	0.00101	CcSEcCtD
Pemetrexed—Hypersensitivity—Pilocarpine—glaucoma	0.000691	0.001	CcSEcCtD
Pemetrexed—Pruritus—Brinzolamide—glaucoma	0.00069	0.001	CcSEcCtD
Pemetrexed—Vomiting—Acetazolamide—glaucoma	0.000688	0.000999	CcSEcCtD
Pemetrexed—Dizziness—Brimonidine—glaucoma	0.000687	0.000998	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Clonidine—glaucoma	0.000682	0.00099	CcSEcCtD
Pemetrexed—Chest pain—Betaxolol—glaucoma	0.00068	0.000987	CcSEcCtD
Pemetrexed—Arthralgia—Betaxolol—glaucoma	0.00068	0.000987	CcSEcCtD
Pemetrexed—Myalgia—Betaxolol—glaucoma	0.00068	0.000987	CcSEcCtD
Pemetrexed—Diarrhoea—Dorzolamide—glaucoma	0.000679	0.000986	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—NGFR—glaucoma	0.000677	0.00273	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GSTT1—glaucoma	0.000677	0.00273	CbGpPWpGaD
Pemetrexed—Diarrhoea—Travoprost—glaucoma	0.000676	0.000981	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000675	0.00098	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—CDKN1B—glaucoma	0.000675	0.00272	CbGpPWpGaD
Pemetrexed—Asthenia—Pilocarpine—glaucoma	0.000673	0.000977	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000673	0.00271	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00067	0.0027	CbGpPWpGaD
Pemetrexed—Arrhythmia—Timolol—glaucoma	0.00067	0.000972	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CA2—glaucoma	0.000669	0.0027	CbGpPWpGaD
Pemetrexed—Dyspnoea—Clonidine—glaucoma	0.000668	0.000969	CcSEcCtD
Pemetrexed—Diarrhoea—Brinzolamide—glaucoma	0.000668	0.000969	CcSEcCtD
Pemetrexed—Pruritus—Pilocarpine—glaucoma	0.000664	0.000963	CcSEcCtD
Pemetrexed—Alopecia—Timolol—glaucoma	0.000663	0.000962	CcSEcCtD
Pemetrexed—Dizziness—Dorzolamide—glaucoma	0.000656	0.000953	CcSEcCtD
Pemetrexed—Rash—Brimonidine—glaucoma	0.000655	0.000951	CcSEcCtD
Pemetrexed—Dermatitis—Brimonidine—glaucoma	0.000655	0.00095	CcSEcCtD
Pemetrexed—Dizziness—Travoprost—glaucoma	0.000653	0.000949	CcSEcCtD
Pemetrexed—Erythema—Timolol—glaucoma	0.000653	0.000947	CcSEcCtD
Pemetrexed—Malnutrition—Timolol—glaucoma	0.000653	0.000947	CcSEcCtD
Pemetrexed—Oedema—Betaxolol—glaucoma	0.000652	0.000946	CcSEcCtD
Pemetrexed—Decreased appetite—Clonidine—glaucoma	0.000651	0.000945	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—OPTN—glaucoma	0.00065	0.00262	CbGpPWpGaD
Pemetrexed—Infection—Betaxolol—glaucoma	0.000648	0.00094	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Clonidine—glaucoma	0.000647	0.000939	CcSEcCtD
Pemetrexed—Fatigue—Clonidine—glaucoma	0.000646	0.000937	CcSEcCtD
Pemetrexed—Dizziness—Brinzolamide—glaucoma	0.000645	0.000937	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—NTRK1—glaucoma	0.000643	0.00259	CbGpPWpGaD
Pemetrexed—Nausea—Acetazolamide—glaucoma	0.000643	0.000934	CcSEcCtD
Pemetrexed—Diarrhoea—Pilocarpine—glaucoma	0.000642	0.000931	CcSEcCtD
Pemetrexed—Shock—Betaxolol—glaucoma	0.000641	0.000931	CcSEcCtD
Pemetrexed—Pain—Clonidine—glaucoma	0.00064	0.00093	CcSEcCtD
Pemetrexed—Constipation—Clonidine—glaucoma	0.00064	0.00093	CcSEcCtD
Pemetrexed—Nervous system disorder—Betaxolol—glaucoma	0.000639	0.000928	CcSEcCtD
Pemetrexed—Dysgeusia—Timolol—glaucoma	0.000639	0.000928	CcSEcCtD
Pemetrexed—Thrombocytopenia—Betaxolol—glaucoma	0.000638	0.000927	CcSEcCtD
Pemetrexed—Skin disorder—Betaxolol—glaucoma	0.000633	0.000919	CcSEcCtD
Pemetrexed—Vomiting—Dorzolamide—glaucoma	0.000631	0.000916	CcSEcCtD
Pemetrexed—Rash—Dorzolamide—glaucoma	0.000626	0.000908	CcSEcCtD
Pemetrexed—Dermatitis—Dorzolamide—glaucoma	0.000625	0.000907	CcSEcCtD
Pemetrexed—Rash—Travoprost—glaucoma	0.000623	0.000904	CcSEcCtD
Pemetrexed—Dermatitis—Travoprost—glaucoma	0.000623	0.000904	CcSEcCtD
Pemetrexed—Anorexia—Betaxolol—glaucoma	0.000622	0.000902	CcSEcCtD
Pemetrexed—Vomiting—Brinzolamide—glaucoma	0.00062	0.000901	CcSEcCtD
Pemetrexed—Dizziness—Pilocarpine—glaucoma	0.00062	0.0009	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000618	0.00249	CbGpPWpGaD
Pemetrexed—Nausea—Brimonidine—glaucoma	0.000617	0.000896	CcSEcCtD
Pemetrexed—Rash—Brinzolamide—glaucoma	0.000615	0.000893	CcSEcCtD
Pemetrexed—Dermatitis—Brinzolamide—glaucoma	0.000615	0.000892	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000614	0.00247	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Clonidine—glaucoma	0.000612	0.000889	CcSEcCtD
Pemetrexed—ATIC—Metabolism—TXN—glaucoma	0.000605	0.00244	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TNF—glaucoma	0.000598	0.00241	CbGpPWpGaD
Pemetrexed—Vomiting—Pilocarpine—glaucoma	0.000596	0.000866	CcSEcCtD
Pemetrexed—Urticaria—Clonidine—glaucoma	0.000595	0.000864	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000594	0.000862	CcSEcCtD
Pemetrexed—Abdominal pain—Clonidine—glaucoma	0.000592	0.000859	CcSEcCtD
Pemetrexed—Body temperature increased—Clonidine—glaucoma	0.000592	0.000859	CcSEcCtD
Pemetrexed—Rash—Pilocarpine—glaucoma	0.000591	0.000858	CcSEcCtD
Pemetrexed—Dermatitis—Pilocarpine—glaucoma	0.000591	0.000858	CcSEcCtD
Pemetrexed—Nausea—Dorzolamide—glaucoma	0.00059	0.000856	CcSEcCtD
Pemetrexed—Nausea—Travoprost—glaucoma	0.000587	0.000852	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000587	0.00237	CbGpPWpGaD
Pemetrexed—Syncope—Timolol—glaucoma	0.000585	0.00085	CcSEcCtD
Pemetrexed—Dyspnoea—Betaxolol—glaucoma	0.000581	0.000844	CcSEcCtD
Pemetrexed—Nausea—Brinzolamide—glaucoma	0.00058	0.000841	CcSEcCtD
Pemetrexed—Dyspepsia—Betaxolol—glaucoma	0.000574	0.000833	CcSEcCtD
Pemetrexed—Loss of consciousness—Timolol—glaucoma	0.000574	0.000833	CcSEcCtD
Pemetrexed—Decreased appetite—Betaxolol—glaucoma	0.000567	0.000823	CcSEcCtD
Pemetrexed—Hypertension—Timolol—glaucoma	0.000563	0.000818	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Betaxolol—glaucoma	0.000563	0.000817	CcSEcCtD
Pemetrexed—Fatigue—Betaxolol—glaucoma	0.000562	0.000816	CcSEcCtD
Pemetrexed—DHFR—G1/S Transition—CDKN1B—glaucoma	0.000562	0.00226	CbGpPWpGaD
Pemetrexed—Constipation—Betaxolol—glaucoma	0.000558	0.000809	CcSEcCtD
Pemetrexed—Pain—Betaxolol—glaucoma	0.000558	0.000809	CcSEcCtD
Pemetrexed—Nausea—Pilocarpine—glaucoma	0.000557	0.000809	CcSEcCtD
Pemetrexed—Myalgia—Timolol—glaucoma	0.000556	0.000807	CcSEcCtD
Pemetrexed—Arthralgia—Timolol—glaucoma	0.000556	0.000807	CcSEcCtD
Pemetrexed—Chest pain—Timolol—glaucoma	0.000556	0.000807	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000552	0.000801	CcSEcCtD
Pemetrexed—Hypersensitivity—Clonidine—glaucoma	0.000552	0.000801	CcSEcCtD
Pemetrexed—SLC46A1—Disease—HDAC9—glaucoma	0.000545	0.0022	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CYP1B1—glaucoma	0.000539	0.00217	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ABCA1—glaucoma	0.000539	0.00217	CbGpPWpGaD
Pemetrexed—Asthenia—Clonidine—glaucoma	0.000537	0.00078	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000534	0.00215	CbGpPWpGaD
Pemetrexed—Oedema—Timolol—glaucoma	0.000533	0.000773	CcSEcCtD
Pemetrexed—Anaphylactic shock—Timolol—glaucoma	0.000533	0.000773	CcSEcCtD
Pemetrexed—Pruritus—Clonidine—glaucoma	0.00053	0.000769	CcSEcCtD
Pemetrexed—Infection—Timolol—glaucoma	0.000529	0.000768	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TP53—glaucoma	0.000527	0.00212	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000526	0.00212	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000525	0.00212	CbGpPWpGaD
Pemetrexed—Shock—Timolol—glaucoma	0.000524	0.000761	CcSEcCtD
Pemetrexed—Nervous system disorder—Timolol—glaucoma	0.000522	0.000758	CcSEcCtD
Pemetrexed—Urticaria—Betaxolol—glaucoma	0.000518	0.000752	CcSEcCtD
Pemetrexed—Skin disorder—Timolol—glaucoma	0.000517	0.000751	CcSEcCtD
Pemetrexed—Body temperature increased—Betaxolol—glaucoma	0.000515	0.000748	CcSEcCtD
Pemetrexed—Diarrhoea—Clonidine—glaucoma	0.000512	0.000744	CcSEcCtD
Pemetrexed—Anorexia—Timolol—glaucoma	0.000508	0.000737	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—FAS—glaucoma	0.000504	0.00203	CbGpPWpGaD
Pemetrexed—Dizziness—Clonidine—glaucoma	0.000495	0.000719	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—CDKN1B—glaucoma	0.00049	0.00197	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CA1—glaucoma	0.000488	0.00197	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Timolol—glaucoma	0.000485	0.000704	CcSEcCtD
Pemetrexed—Hypersensitivity—Betaxolol—glaucoma	0.00048	0.000697	CcSEcCtD
Pemetrexed—Vomiting—Clonidine—glaucoma	0.000476	0.000691	CcSEcCtD
Pemetrexed—Dyspnoea—Timolol—glaucoma	0.000475	0.000689	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000473	0.00191	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CTSA—glaucoma	0.000473	0.00191	CbGpPWpGaD
Pemetrexed—Rash—Clonidine—glaucoma	0.000472	0.000685	CcSEcCtD
Pemetrexed—Dermatitis—Clonidine—glaucoma	0.000472	0.000685	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—TXN—glaucoma	0.000471	0.0019	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTT1—glaucoma	0.000469	0.00189	CbGpPWpGaD
Pemetrexed—Dyspepsia—Timolol—glaucoma	0.000469	0.000681	CcSEcCtD
Pemetrexed—DHFR—Disease—HEYL—glaucoma	0.000468	0.00189	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR1OP—glaucoma	0.000468	0.00189	CbGpPWpGaD
Pemetrexed—Asthenia—Betaxolol—glaucoma	0.000468	0.000679	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000466	0.00188	CbGpPWpGaD
Pemetrexed—Decreased appetite—Timolol—glaucoma	0.000463	0.000672	CcSEcCtD
Pemetrexed—Pruritus—Betaxolol—glaucoma	0.000461	0.00067	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Timolol—glaucoma	0.00046	0.000667	CcSEcCtD
Pemetrexed—Fatigue—Timolol—glaucoma	0.000459	0.000667	CcSEcCtD
Pemetrexed—Pain—Timolol—glaucoma	0.000456	0.000661	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000449	0.00181	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CA2—glaucoma	0.000446	0.0018	CbGpPWpGaD
Pemetrexed—Diarrhoea—Betaxolol—glaucoma	0.000446	0.000648	CcSEcCtD
Pemetrexed—Nausea—Clonidine—glaucoma	0.000445	0.000646	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Timolol—glaucoma	0.000436	0.000632	CcSEcCtD
Pemetrexed—GART—Metabolism—GSTM1—glaucoma	0.000431	0.00174	CbGpPWpGaD
Pemetrexed—Dizziness—Betaxolol—glaucoma	0.000431	0.000626	CcSEcCtD
Pemetrexed—Urticaria—Timolol—glaucoma	0.000423	0.000614	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000423	0.0017	CbGpPWpGaD
Pemetrexed—Body temperature increased—Timolol—glaucoma	0.000421	0.000611	CcSEcCtD
Pemetrexed—Abdominal pain—Timolol—glaucoma	0.000421	0.000611	CcSEcCtD
Pemetrexed—Vomiting—Betaxolol—glaucoma	0.000415	0.000602	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000413	0.00166	CbGpPWpGaD
Pemetrexed—Rash—Betaxolol—glaucoma	0.000411	0.000597	CcSEcCtD
Pemetrexed—Dermatitis—Betaxolol—glaucoma	0.000411	0.000596	CcSEcCtD
Pemetrexed—Hypersensitivity—Timolol—glaucoma	0.000392	0.00057	CcSEcCtD
Pemetrexed—DHFR—Metabolism—CA1—glaucoma	0.000392	0.00158	CbGpPWpGaD
Pemetrexed—Nausea—Betaxolol—glaucoma	0.000387	0.000562	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND2—glaucoma	0.000382	0.00154	CbGpPWpGaD
Pemetrexed—Asthenia—Timolol—glaucoma	0.000382	0.000555	CcSEcCtD
Pemetrexed—GART—Metabolism—MTHFR—glaucoma	0.000381	0.00154	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CTSA—glaucoma	0.00038	0.00153	CbGpPWpGaD
Pemetrexed—Pruritus—Timolol—glaucoma	0.000377	0.000547	CcSEcCtD
Pemetrexed—ATIC—Metabolism—ABCA1—glaucoma	0.000374	0.00151	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP1B1—glaucoma	0.000374	0.00151	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000369	0.00149	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTT1—glaucoma	0.000366	0.00147	CbGpPWpGaD
Pemetrexed—Diarrhoea—Timolol—glaucoma	0.000364	0.000529	CcSEcCtD
Pemetrexed—DHFR—Metabolism—CA2—glaucoma	0.000359	0.00145	CbGpPWpGaD
Pemetrexed—GART—Metabolism—APOE—glaucoma	0.000355	0.00143	CbGpPWpGaD
Pemetrexed—Dizziness—Timolol—glaucoma	0.000352	0.000511	CcSEcCtD
Pemetrexed—GART—Metabolism—CAV1—glaucoma	0.000352	0.00142	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000343	0.00138	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CA1—glaucoma	0.000342	0.00138	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND2—glaucoma	0.000342	0.00138	CbGpPWpGaD
Pemetrexed—Vomiting—Timolol—glaucoma	0.000339	0.000492	CcSEcCtD
Pemetrexed—Rash—Timolol—glaucoma	0.000336	0.000487	CcSEcCtD
Pemetrexed—Dermatitis—Timolol—glaucoma	0.000336	0.000487	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND2—glaucoma	0.000334	0.00134	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CTSA—glaucoma	0.000332	0.00134	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00033	0.00133	CbGpPWpGaD
Pemetrexed—Nausea—Timolol—glaucoma	0.000316	0.000459	CcSEcCtD
Pemetrexed—DCK—Metabolism—TXN—glaucoma	0.000315	0.00127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CA2—glaucoma	0.000313	0.00126	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000313	0.00126	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2B—glaucoma	0.000306	0.00124	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000299	0.00121	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTM1—glaucoma	0.000299	0.0012	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND2—glaucoma	0.000298	0.0012	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN2B—glaucoma	0.000293	0.00118	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HDAC9—glaucoma	0.000292	0.00118	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP1B1—glaucoma	0.000291	0.00117	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ABCA1—glaucoma	0.000291	0.00117	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2B—glaucoma	0.000267	0.00108	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NOS3—glaucoma	0.000266	0.00107	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—MTHFR—glaucoma	0.000264	0.00106	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.00026	0.00105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TXN—glaucoma	0.000253	0.00102	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOE—glaucoma	0.000246	0.000991	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTHFR—glaucoma	0.000246	0.00099	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTT1—glaucoma	0.000244	0.000983	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CAV1—glaucoma	0.000244	0.000982	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—glaucoma	0.000243	0.00098	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTM1—glaucoma	0.000233	0.000939	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOE—glaucoma	0.000229	0.000922	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CAV1—glaucoma	0.000227	0.000914	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000223	0.000899	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TXN—glaucoma	0.000221	0.000889	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BAD—glaucoma	0.000213	0.000859	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—glaucoma	0.000206	0.00083	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000197	0.000792	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTT1—glaucoma	0.000196	0.00079	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000196	0.00079	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCA1—glaucoma	0.000194	0.000783	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1B1—glaucoma	0.000194	0.000783	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOE—glaucoma	0.000192	0.000772	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAV1—glaucoma	0.00019	0.000765	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—glaucoma	0.000189	0.000761	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NOS3—glaucoma	0.000184	0.000743	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—glaucoma	0.000175	0.000706	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000174	0.0007	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS3—glaucoma	0.000171	0.000691	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTT1—glaucoma	0.000171	0.000689	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000171	0.000689	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—glaucoma	0.000169	0.000679	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN2B—glaucoma	0.000157	0.000634	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—glaucoma	0.000157	0.000632	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1B1—glaucoma	0.000156	0.00063	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCA1—glaucoma	0.000156	0.00063	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—glaucoma	0.000155	0.000626	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1B—glaucoma	0.000155	0.000625	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—glaucoma	0.000153	0.000616	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000151	0.00061	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1B—glaucoma	0.000148	0.000598	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NOS3—glaucoma	0.000144	0.000579	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—glaucoma	0.000137	0.000553	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCA1—glaucoma	0.000136	0.000549	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1B1—glaucoma	0.000136	0.000549	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1B—glaucoma	0.000135	0.000546	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—glaucoma	0.000132	0.000531	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—glaucoma	0.000131	0.000529	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOE—glaucoma	0.000128	0.000515	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAV1—glaucoma	0.000127	0.000511	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—glaucoma	0.000125	0.000503	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOE—glaucoma	0.000123	0.000494	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CAV1—glaucoma	0.000122	0.00049	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BAD—glaucoma	0.000114	0.000461	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—glaucoma	0.00011	0.000445	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—glaucoma	0.000109	0.000439	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOE—glaucoma	0.000103	0.000414	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAV1—glaucoma	0.000102	0.00041	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—glaucoma	9.75e-05	0.000393	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—glaucoma	9.63e-05	0.000388	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NOS3—glaucoma	9.58e-05	0.000386	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS3—glaucoma	9.19e-05	0.00037	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOE—glaucoma	8.96e-05	0.000361	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAV1—glaucoma	8.88e-05	0.000358	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—glaucoma	8.76e-05	0.000353	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—glaucoma	8.51e-05	0.000343	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—glaucoma	8.41e-05	0.000339	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1B—glaucoma	7.96e-05	0.000321	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NOS3—glaucoma	7.7e-05	0.00031	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—glaucoma	7.04e-05	0.000284	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NOS3—glaucoma	6.72e-05	0.000271	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—glaucoma	6.14e-05	0.000248	CbGpPWpGaD
